151 related articles for article (PubMed ID: 32132178)
1. Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy.
Goselink RJM; Schreuder THA; Mul K; Voermans NC; Erasmus CE; van Engelen BGM; van Alfen N
Neurology; 2020 Apr; 94(14):e1488-e1494. PubMed ID: 32132178
[TBL] [Abstract][Full Text] [Related]
2. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
3. Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy.
Vincenten SCC; Teeselink S; Voermans NC; van Engelen BGM; Mul K; van Alfen N
Neuromuscul Disord; 2023 Dec; 33(12):936-944. PubMed ID: 37968164
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
[TBL] [Abstract][Full Text] [Related]
5. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
[TBL] [Abstract][Full Text] [Related]
6. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.
Fatehi F; Salort-Campana E; Le Troter A; Lareau-Trudel E; Bydder M; Fouré A; Guye M; Bendahan D; Attarian S
PLoS One; 2017; 12(8):e0183825. PubMed ID: 28841698
[TBL] [Abstract][Full Text] [Related]
8. Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Mul K; Heatwole C; Eichinger K; Dilek N; Martens WB; Van Engelen BGM; Tawil R; Statland JM
Muscle Nerve; 2018 Aug; 58(2):213-218. PubMed ID: 29543984
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.
Gijsbertse K; Goselink R; Lassche S; Nillesen M; Sprengers A; Verdonschot N; van Alfen N; de Korte C
Ultrasound Med Biol; 2017 Nov; 43(11):2537-2545. PubMed ID: 28764967
[TBL] [Abstract][Full Text] [Related]
10. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
[TBL] [Abstract][Full Text] [Related]
11. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
[TBL] [Abstract][Full Text] [Related]
12. A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD).
Petek LM; Rickard AM; Budech C; Poliachik SL; Shaw D; Ferguson MR; Tawil R; Friedman SD; Miller DG
Neuromuscul Disord; 2016 Jul; 26(7):405-13. PubMed ID: 27185459
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy.
Veltsista D; Chroni E
Acta Neurol Scand; 2021 Aug; 144(2):216-220. PubMed ID: 33844852
[TBL] [Abstract][Full Text] [Related]
14. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.
Mellion ML; Widholm P; Karlsson M; Ahlgren A; Tawil R; Wagner KR; Statland JM; Wang L; Shieh PB; van Engelen BGM; Kools J; Ronco L; Odueyungbo A; Jiang J; Han JJ; Hatch M; Towles J; Leinhard OD; Cadavid D
Neurology; 2022 Aug; 99(9):e877-e889. PubMed ID: 35750498
[TBL] [Abstract][Full Text] [Related]
16. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
[TBL] [Abstract][Full Text] [Related]
18. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
[TBL] [Abstract][Full Text] [Related]
19. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
[TBL] [Abstract][Full Text] [Related]
20. Correlation between whole body muscle MRI and functional measures in paediatric patients with facioscapulohumeral muscular dystrophy.
Woodcock IR; de Valle K; Varma N; Kean M; Ryan MM
Neuromuscul Disord; 2023 Jan; 33(1):15-23. PubMed ID: 36522253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
